Idex Corporation ( (IEX) ) has released its Q4 earnings. Here is a breakdown of the information Idex Corporation presented to its investors.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
IDEX Corporation is a diversified, global company that designs and manufactures engineered products and components across various industries, including health and science technologies, fluid and metering technologies, and fire and safety. Known for its precision components, IDEX plays a significant role in sectors ranging from water treatment to rescue operations with products like the Hurst Jaws of Life.
IDEX Corporation recently announced its financial results for the fourth quarter and full year of 2024, reporting record sales in the fourth quarter and a stable performance over the year. Despite facing challenges, the company maintains its focus on strategic growth, including recent acquisitions and strong performance in certain market segments.
In the fourth quarter of 2024, IDEX achieved record sales of $863 million, marking a 9% increase from the previous year, with adjusted diluted earnings per share (EPS) rising by 11% to $2.04. However, the company’s operating cash flow and free cash flow decreased by 14% and 12%, respectively. For the full year, IDEX reported $3.3 billion in sales, with a slight decline in organic sales. Adjusted diluted EPS was down 4% at $7.89, reflecting challenges in operating performance and higher expenses.
Despite the financial pressures, IDEX’s Health & Science Technologies segment performed well, driven by acquisitions like Mott Corporation, and the Fire & Safety/Diversified Products segment saw record sales. The company’s strategic focus on price capture and operational productivity has been crucial in offsetting market headwinds and achieving growth.
Looking forward, IDEX projects a slight increase in organic sales for 2025, with a full-year GAAP diluted EPS forecast of $6.56 to $6.96. The company remains committed to leveraging its 80/20 strategy to focus resources on the best opportunities and is optimistic about achieving double-digit earnings growth through both organic and inorganic means.
